How much funding has Delphia Therapeutics raised?

Delphia Therapeutics has raised $67.0M in total funding, most recently a Series A round.

Who are Delphia Therapeutics's investors?

Delphia Therapeutics's investors include GV (Google Ventures), Nextech Invest, Alexandria Venture Investments, Polaris Partners.

When was Delphia Therapeutics founded?

Delphia Therapeutics was founded in 2024.

Where is Delphia Therapeutics headquartered?

Delphia Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Delphia Therapeutics in?

Delphia Therapeutics operates in Biotech, Therapeutics.

How many employees does Delphia Therapeutics have?

Delphia Therapeutics has 11-50 employees.

Delphia Therapeutics

Cambridge, United States · Founded 2024 · $67.0M raised

Biotech

Therapeutics

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2024
Business Model: B2B

Website: delphiatx.com
Total Funding: $67.0M
Last Round: $67.0M Series AMay 2024
Rounds: 1

About

Biotech developing 'activation lethality' cancer therapeutics that overactivate oncogenes to selectively kill tumor cells.

Summary

Delphia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2024. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in May 2024. Investors include GV (Google Ventures), Nextech Invest and Alexandria Venture Investments.